Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Patient Preference and Adherence Volume 9, 2015 - Issue

Submit an article Journal homepage

Open access

108

Views

CrossRef citations to date

Altmetric

Original Research

Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer

Beth A Fordham1 ICON Patient Reported Outcomes, Oxford, UK

Cicely Kerr1 ICON Patient Reported Outcomes, Oxford, UK

Hayley M de Freitas1 ICON Patient Reported Outcomes, Oxford, UKCorrespondence[email protected]

Andrew J Lloyd1 ICON Patient Reported Outcomes, Oxford, UK

Karissa Johnston2 ICON Epidemiology, Toronto, ON, Canada

Corey L Pelletier3 Eisai Inc., NJ, USA

Gabriel Tremblay3 Eisai Inc., NJ, USA

Anna Forsythe3 Eisai Inc., NJ, USA

Bryan McIver4 Moffitt Cancer Center, FL, USA

Ezra EW Cohen5 University of California San Diego Moores Cancer Center, La Jolla, CA, USA

show all

Pages 1561-1572 | Published online: 03 Nov 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Youwen Zhu, Kun Liu, Kailing Wang & Libo Peng. (2022) Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis. Frontiers in Endocrinology 13.
Crossref

Bo Shi, Wenbiao Ma, Hongshuai Pan, Yang Shi, Huan Zhang & Shenghai Xing. (2022) Cost-Effectiveness of Apatinib and Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer. Frontiers in Pharmacology 13.
Crossref

Nigel Fleeman, Rachel Houten, Adrian Bagust, Marty Richardson, Sophie Beale, Angela Boland, Yenal Dundar, Janette Greenhalgh, Juliet Hounsome, Rui Duarte & Aditya Shenoy. (2020) Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. Health Technology Assessment 24:2, pages 1-180.
Crossref

Paul Tappenden, Christopher Carroll, Jean Hamilton, Eva Kaltenthaler, Ruth Wong, Jonathan Wadsley, Laura Moss & Sabapathy Balasubramanian. (2019) Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model. Health Technology Assessment 23:8, pages 1-144.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references